Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3143 results found
Expand All
Apply All
3143 results found

Transforming HIV/AIDS into a Chronic Condition
Share
Human Health, Disease Area  •  Toolkit  •  January 17, 2016
Advancements by the biopharmaceutical sector have radically altered the trajectory of HIV/AIDS. What once was a death sentence is now a manageable chronic condition for millions of Americans.
Read More

Cancer Medicines
Share
Human Health, Disease Area  •  Toolkit  •  January 16, 2016
Biopharmaceutical research and development is uncovering new insights into how we view, understand and treat cancer, helping to transform a terrifying diagnosis into a healthier and longer life for patients.
Read More

Stemming the Coming Alzheimer's Tsunami
Share
Patient Advocacy, Disease Area  •  Toolkit  •  January 15, 2016
As Baby Boomers age, the rate of Alzheimer's disease will reach epidemic proportions. Unless new breakthrough treatments are developed soon, the consequences will be devastating for patients, families, and our healthcare system.
Read More

Registration for the 2016 BIO International Convention Now Open
Share
Business Development, BIO One-on-One Partnering  •  Press Release  •  January 14, 2016
Washington, D.C. (January 14, 2016) – The Biotechnology Innovation Organization (BIO) announced today that registration is now open for the 2016 BIO International Convention®. BIO 2016 will take place June 6-9, 2016 at the Moscone Center in San Francisco, California. The BIO International Convention is where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world.“We excited to bring the BIO International Convention back to San Francisco. Many biotech milestones hail from the Golden State: the first biotech company, the first biotech IPO and the first FDA-approved biotech drug to name just a few,” said Scott Whitaker, president of the BIO International Convention. “The BIO Convention, and our industry as a whole, have made tremendous strides since the last time our Convention was hosted in San Francisco in 2004.“In the decade since then, the number of partnering meetings has increased nearly four hundred percent, as companies and nonprofits continue to make connections and form partnerships that are critical to advancing their business interests. To keep up with the demand for partnering opportunities, I am pleased to announce that we will be adding an additional half-day to BIO One-on-One Partnering™ Monday afternoon.”BIO 2016 offers the chance to connect with more than 3,100 companies through BIO’s One-on-One Partnering™ system as well as the world’s largest biotechnology exhibition – the BIO Exhibition, which is now over eighty percent sold. The BIO Exhibition will once again feature the Start-Up Stadium, where start-up companies will have the opportunity to pitch to key members of the investment community, venture philanthropy groups, and BIO attendees, as well as the Innovation Zone, featuring select companies who have received SBIR/STTR grants from the National…
Read More

BIO Welcomes Support of Vice President Biden in Fight to Cure Cancer
Share
Press Release  •  January 12, 2016
Washington, D.C. (January 12, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding Vice President Joe Biden’s “moon shot” initiative to find a cure for cancer.
Read More

2016 BIO CEO & Investor Conference Buzz of BIO Winners Announced
Share
Press Release  •  January 12, 2016
Recognizing highly innovative companies in the biotech sector
Read More

BIO Announces Appointment of Dan Durham to Lead Health Policy Section
Share
Press Release  •  January 7, 2016
BIO announced today that long-time healthcare policy expert Dan Durham will be joining BIO as Executive Vice President and will lead the organization’s Health Policy Section.
Read More

Biotechnology Industry Organization changes name to Biotechnology Innovation Organization
Share
Press Release  •  January 4, 2016
New Name Better Reflects Member's Innovations and Breakthroughs; Organization Will Still Use BIO Name
Read More

Congressional Black Caucus Letter to EPA on RFS RVO
Share
Agriculture & Environment, Sustainable Fuels, Renewable Fuel Standard (RFS)  •  Letters, Testimony & Comments  •  October 30, 2015
As you finalize the proposed rules under the Renewable Fuel Standard, we respectfully urge you to not reduce the biofuels volume requirements. The RFS program has helped the environment, our economy, and has increased our confidence in renewable fuels. Renewable fuels like cellulosic and advanced biofuels have reduced greenhouse gas and carbon emissions to an equivalent of removing more than 124 million cars from the roads. 
Read More

BIO Submits Comments Re: FDA Rare Diseases Guidance
Share
Rare Diseases  •  Letters, Testimony & Comments  •  October 22, 2015
RE: Docket No. FDA–2015–D–2818 Draft Guidance for Industry: Rare Diseases—Common Issues in Drug Development Dear Sir/Madam: The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide feedback in response to the Food and Drug Administration’s (FDA’s) Draft Guidance for Industry, entitled “Rare Diseases: Common Issues in Drug Development” (Draft Guidance). BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 313
  • 314
  • 315
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO